| Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development C Robin, K Bollerot, S Mendes, E Haak, M Crisan, F Cerisoli, I Lauw, ... Cell stem cell 5 (4), 385-395, 2009 | 289 | 2009 |
| Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target S Safe, P Imanirad, S Sreevalsan, V Nair, I Jutooru Expert opinion on therapeutic targets 18 (7), 759-769, 2014 | 111 | 2014 |
| HIF1α is a regulator of hematopoietic progenitor and stem cell development in hypoxic sites of the mouse embryo P Imanirad, PS Kartalaei, M Crisan, C Vink, T Yamada-Inagawa, ... Stem cell research 12 (1), 24-35, 2014 | 78 | 2014 |
| Identification of three novel TECTA mutations in Iranian families with autosomal recessive nonsyndromic hearing impairment at the DFNB21 locus NC Meyer, F Alasti, CJ Nishimura, P Imanirad, K Kahrizi, Y Riazalhosseini, ... American Journal of Medical Genetics Part A 143 (14), 1623-1629, 2007 | 61 | 2007 |
| Hypoxia and HIFs in regulating the development of the hematopoietic system P Imanirad, E Dzierzak Blood Cells, Molecules, and Diseases 51 (4), 256-263, 2013 | 53 | 2013 |
| Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer Y Cheng, P Imanirad, I Jutooru, E Hedrick, UH Jin, A Rodrigues Hoffman, ... PLoS One 13 (2), e0192264, 2018 | 42 | 2018 |
| Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC SU Gandhy, P Imanirad, UH Jin, V Nair, E Hedrick, Y Cheng, JC Corton, ... Oncotarget 6 (28), 26359, 2015 | 35 | 2015 |
| Precision combination therapies based on recurrent oncogenic coalterations X Li, EK Dowling, G Yan, Z Dereli, B Bozorgui, P Imanirad, JH Elnaggar, ... Cancer discovery 12 (6), 1542-1559, 2022 | 17 | 2022 |
| Hematopoietic progenitor and stem cell regulation during development: hypoxia and niches P Imanirad | 2 | 2013 |
| Role of hypoxia in hematopoietic progenitor and stem cell generation and function during mouse ontogeny P Imanirad, PS Kartalaei, M Crisan, T Yamada-Inagawa, ... EXPERIMENTAL HEMATOLOGY 40 (8), S19-S20, 2012 | 1 | 2012 |
| Abstract LB119: Precision combination therapies based on recurrent oncogenic co-alterations A Korkut, X Li, E Kong, G Yan, Z Dereli, B Bozorgui, P Imanirad, ... Cancer Research 82 (12_Supplement), LB119-LB119, 2022 | | 2022 |
| The Effects of Hypoxia on Hematopoietic Cells and Their Niche in the Developing Mouse Placenta P Imanirad, D Kurek, R van den Linden, M Lauw, M Crisan, E Dzierzak Hematopoietic Progenitor and Stem Cell Regulation during Development …, 2013 | | 2013 |
| ROLE OF HYPDXIA IN HEMATOPOIETIC PROGENITOR AND STEM CELL GENERATION AND FUNCTION DURING MOUSE ONTOGENY P Imanirad, PS Kartalaei, M Crisan, T Yamada-Inagawa, ... EXPERIMENTAL HEMATOLOGY 40 (8), S100-S101, 2012 | | 2012 |
| POSTER PRESENTATIONS; HUMAN PLACENTA IS A POTENT HEMATOPOIETIC NICHE CONTAINING HEMATOPOIETIC STEM AND PROGENITOR CELLS THROUGHOUT DEVELOPMENT C ROBIN, K BOLLEROT, S MENDES, E HAAK, M CRISAN, P IMANIRAD, ... CELL JOURNAL (YAKHTEH) 12 (16), 42-42, 2010 | | 2010 |
| Screening for DFNB1, DFNB2, DFNB3, DFNB4, DFNB9 and DFNB21 loci in the Iranian patients with autosomal recessive non-syndromic hearing loss Y Riazalhosseini, A Daneshi, P Imanirad, M Mohseni, N Bazazzadegan, ... JOURNAL OF MEDICAL GENETICS 42, S102-S102, 2005 | | 2005 |
| Supplementary Materials and Methods for Precision combination therapies based on recurrent oncogenic co-alterations X Li, EK Dowling, G Yan, Z Dereli, B Bozorgui, P Imanirad, JH Elnaggar, ... | | |
| Role of the long non-coding RNA MALAT-1 in Pancreatic Cancer Y Cheng, P Imanirad, I Jutooru, AR Hoffmann, B Morpurgo, AE Golovko, ... | | |
| Use of the Gene Trap Resource for Cancer-related lncRNAs to Study the Role of Malat1 in Pancreatic Cancer. A Golovko, H Guo, A Gonzales, SH Safe, I Jutooru, P Imanirad, ... | | |
